Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed)

The summary for the Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed): The purpose of this funding opportunity is to encourage small businesses to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to better understand and manipulate the dynamic structure and/or function of brain localized G-protein coupled receptors (GPCRs) and/or potentially identify novel selective and specific agonists, antagonists, or allosteric modulators for these receptor subtypes, with a focus on mental health function or dysfunction. Technologies and approaches aimed at either well characterized receptor subtypes or understudied/orphan receptors would be of potential interest to NIMH.
Federal Grant Title: Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-18-708
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Information not provided
Current Application Deadline: September 5th, 2021
Original Application Deadline: September 5th, 2021
Posted Date: March 15th, 2018
Creation Date: March 15th, 2018
Archive Date: October 11th, 2021
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: March 15th, 2018
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-18-708.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Bra...
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-expo...
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites ...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
Summer Research Education Experience Program (Clinical Trials Not Allowed R25)
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/...
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinica...
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Lab...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com